DPIIT recognised startup Government of India
Startup India
Redicine Medsol Private Limited - internet in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.43 Lakh
▼ 74% YoY
Net loss · FY 2025
₹40.67 Lakh
Latest filing
EBITDA · FY 2025
-₹39.36 Lakh
Latest filing
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹56,640
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Redicine Medsol Private Limited
Data last updated:
Redicine Medsol Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the online healthcare services segment of the internet and digital services sector. It was incorporated on 29 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33100GJ2020PTC114237. Its GSTIN is 24AAKCR2348P1ZV (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹56,640. It is led by directors including Raj Urvish Shah and Dhaumil Dipakkumar Parmar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1161/94 352 Uday Apartments Near Telephone Exchange Naranpura, Ahmedabad, Gujarat, India – 380063.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.43 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹40.67 Lakh and EBITDA of -₹39.36 Lakh.
The company is associated with 1 brand: Redicine Medsol. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹80 Lakh; the latest was in October 2022.
Redicine Medsol Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0241473). For more details, the company can be reached via its website redicinemedsol.com.
Company details
CIN U33100GJ2020PTC114237
Registration Number 114237
Incorporation Date 29 June 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0241473
Key People
Raj Urvish Shah Director Dhaumil Dipakkumar Parmar Director Kush Kirtikumar Prajapati Director Recognitions & Rankings of Redicine Medsol
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0241473
Contact details
Redicine Medsol Private Limited's registered office is in Ahmedabad, Gujarat. Its website is redicinemedsol.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address1161/94 352 Uday Apartments Near Telephone Exchange Naranpura, Ahmedabad, Gujarat, India – 380063
- IndustryInternet, Online Healthcare Services
To see the full contact details of Redicine Medsol Private Limited, buy the company report.
Comprehensive company report
Redicine Medsol Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Redicine Medsol operates one associated brand: Redicine Medsol. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medical adherence devices are supplied for cardiac and cancer patients. | redicinemedsol.com |
Business activity
The main business activity of Redicine Medsol is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
To see the full business activity and turnover split of Redicine Medsol Private Limited, buy the company report.
Financials of Redicine Medsol Private Limited
FY 2025 filings availableRedicine Medsol Private Limited reported revenue of ₹4.43 Lakh (down 74% YoY) for FY 2025.
Revenue · FY 2025
₹4.43 Lakh ▼ 74%
Net loss · FY 2025
₹40.67 Lakh
EBITDA · FY 2025
-₹39.36 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 74%
EBITDA CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 33%
Revenue fell 74% in the latest year. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹39.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹40.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Redicine Medsol Private Limited, buy the company report.
Board of directors of Redicine Medsol Private Limited
Redicine Medsol has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Urvish Shah | Director | 01 Apr 2022 | 4 Years 7 Months | Current |
| Dhaumil Dipakkumar Parmar | Director | 29 Jun 2020 | 6 Years 4 Months | Current |
| Kush Kirtikumar Prajapati | Director | 29 Jun 2020 | 6 Years 4 Months | Current |
Auditor
Redicine Medsol Private Limited is audited by Parikh & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Parikh & Associates | FY 2024 | 146545W |
Shareholding
The shareholding of Redicine Medsol Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Redicine Medsol Private Limited, buy the company report.
Deals & funding
Redicine Medsol Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹80 Lakh; the latest was in October 2022.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹80 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2022 | Funding round | ₹80 Lakh | Investors: Devx Accel, Unitve Ventures LLP , 2 individuals |
| Jan 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Redicine Medsol Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Redicine Medsol Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Redicine Medsol has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCR2348P1ZV | Gujarat | Active | 16 Oct 2020 |
To see the full GST registrations and return filing status of Redicine Medsol Private Limited, buy the company report.
Recent activity
Redicine Medsol Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Raj Urvish Shah was appointed as Director on 01 Apr 2022.
AGM
Redicine Medsol Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Redicine Medsol Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Raj Urvish Shah was appointed as Director.
Ceased
Harsh Yogeshbhai Mangukiya ceased to be Director.
Appointed
Dhaumil Dipakkumar Parmar was appointed as Director.
Appointed
Kush Kirtikumar Prajapati was appointed as Director.
Incorporation
29 Jun 2020
Redicine Medsol Private Limited was registered on 29 Jun 2020 with Roc Ahmedabad & aged 6 years 4 months as per MCA records.
Frequently asked questions
Redicine Medsol is an active private limited company based in Ahmedabad, Gujarat, India. The company works in online healthcare services, within the internet industry. It was incorporated on 29 June 2020 (6+ years old) and is registered under CIN U33100GJ2020PTC114237.
Redicine Medsol has 3 current directors:
- Raj Urvish Shah - Director
- Dhaumil Dipakkumar Parmar - Director
- Kush Kirtikumar Prajapati - Director
The latest financial statements of Redicine Medsol on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Redicine Medsol is 24AAKCR2348P1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Redicine Medsol is U33100GJ2020PTC114237. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Redicine Medsol was incorporated on 29 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Redicine Medsol has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹80 Lakh; the latest was in October 2022.
Raj Urvish Shah was appointed as Director on 01 Apr 2022. Harsh Yogeshbhai Mangukiya ceased to be Director on 18 Dec 2020. Dhaumil Dipakkumar Parmar was appointed as Director on 29 Jun 2020. Redicine Medsol has 4 board changes on record in total.
Yes, Redicine Medsol is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Redicine Medsol is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0241473).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages